I now have all the information I need for a comprehensive, well-organized answer. Here it is:
Management of UTI in Pregnant Women
UTI in pregnancy encompasses three clinical entities: asymptomatic bacteriuria (ASB), acute cystitis, and acute pyelonephritis. All three require active treatment because untreated bacteriuria in pregnancy can lead to pyelonephritis (in up to 30% of untreated cases), preterm labor, low birth weight, and maternal sepsis.
Why Pregnancy Increases UTI Risk
Pregnancy creates a permissive environment for ascending infection through several mechanisms:
- Progesterone-induced smooth muscle relaxation inhibits ureteral peristalsis
- Mechanical ureteral compression causes hydronephrosis (right > left; 75% vs. 33% after mid-pregnancy)
- Bladder compression leads to incomplete emptying
- Glycosuria promotes bacterial growth
Together, these factors promote urinary stasis and allow bacteria to ascend from the perineum. - Rosen's Emergency Medicine, Comprehensive Clinical Nephrology 7th Ed.
Common Causative Organisms
| Organism | Notes |
|---|
| E. coli | >70-85% of all cases; virulent strains with fimbriae enable urothelial attachment |
| Klebsiella spp. | Second most common |
| Proteus spp. | More common in diabetic women or urinary obstruction |
| Enterococci | |
| Staphylococcus saprophyticus | |
| Group B Streptococcus (GBS) | Requires special considerations (see below) |
| Pseudomonas | Less common; associated with resistance |
1. Asymptomatic Bacteriuria (ASB)
Diagnosis
- Defined as >10^5 CFU/mL on urine culture in a woman with no symptoms
- Screen all pregnant women at 12-16 weeks gestation (or first prenatal visit if later) - US Preventive Services Task Force Grade A recommendation
- Primary urine culture is preferred over dipstick (dipstick has limited sensitivity; pyuria from vaginal contamination is common in pregnancy)
Why Treat?
ASB in pregnancy progresses to pyelonephritis in up to 30% of untreated women. Treatment reduces pyelonephritis risk by >80% and may reduce preterm delivery and low birth weight. - Rosen's Emergency Medicine, Comprehensive Clinical Nephrology 7th Ed.
Antibiotic Treatment (7-day course recommended)
| Antibiotic | Dose | Notes |
|---|
| Amoxicillin | 500 mg PO TID x 7 days | First-line; avoid if high local resistance |
| Cephalexin | 500 mg PO BID-QID x 3-7 days | First-line; safe throughout pregnancy |
| Nitrofurantoin | 100 mg PO BID x 5-7 days | Avoid in 1st trimester (possible birth defects) and near term (neonatal hemolysis risk) |
| Amoxicillin-clavulanate | Standard dose | Broader spectrum; reasonable option |
| Fosfomycin | Single 3g dose | Safe in pregnancy; good option with multi-drug resistant organisms |
| TMP-SMX | 800/160 mg BID x 3 days | 2nd/3rd trimester only - avoid 1st trimester (antifolate) and 3rd trimester (kernicterus risk) |
| Trimethoprim alone | After 1st trimester | Avoid in folate deficiency or with other folate antagonists |
Avoid throughout pregnancy: Fluoroquinolones (cartilage toxicity) and tetracyclines (fetal bone/teeth effects).
- A follow-up urine culture after treatment is essential to confirm eradication.
- Without treatment, ASB persists in 80% of women. Even with treatment, 20% have persistent bacteriuria, and only 40% are eradicated with a second course.
- Where eradication fails repeatedly, prophylactic antibiotics until delivery may be considered.
Source: Comprehensive Clinical Nephrology 7th Ed., Tintinalli's Emergency Medicine, Rosen's Emergency Medicine
2. Acute Cystitis
Diagnosis
- Lower urinary tract symptoms: dysuria, frequency, urgency, strangury
- Pyuria + positive culture (as few as 10^2 CFU/mL may be diagnostic if symptoms are present)
- Obtain urinalysis and culture with sensitivities in all pregnant women with urinary tract symptoms
Treatment
- Same antibiotics as ASB with the same safety considerations
- A follow-up urine culture is recommended to confirm eradication
- Recurrent infections are common due to glycosuria and mechanical ureteral compression in the 3rd trimester
3. Acute Pyelonephritis
Clinical Features
- Fever, loin/flank pain, malaise, nausea, vomiting
- Most common between 20-28 weeks gestation
- Right-sided predominance due to greater right ureteral dilation
- May present as acute abdominal pain; can precipitate preterm labor (via pro-inflammatory cytokines from bacterial endotoxins)
- Can progress to bacteremia, AKI, DIC, and septic shock
Management
- Hospitalize most patients (outpatient management only for mild, reliable cases)
- IV hydration, obstetric consultation, urine and blood cultures
- Prompt empirical IV antibiotics - do not wait for culture results:
- Ceftriaxone 1g IV once daily - first choice (due to high E. coli ampicillin resistance)
- Ampicillin + Gentamicin - alternative (note: ampicillin resistance is high in many regions)
- Adjust antibiotics based on culture and sensitivity results
- Transition to oral antibiotics when clinically improving
- Total course: 10-14 days
- Repeat urine culture after treatment (test of cure)
- Prophylactic antibiotics until delivery are recommended after an episode to prevent recurrence and reduce preterm labor risk
- Kidney ultrasound to assess anatomy; indicated in non-responders to rule out obstruction, pyonephrosis, or perinephric abscess
- If obstructed infected kidney confirmed on imaging: percutaneous nephrostomy under ultrasound guidance may be required
Source: Comprehensive Clinical Nephrology 7th Ed., Rosen's Emergency Medicine
4. Special Case: Group B Streptococcus (GBS) in Urine
- GBS colony count >100,000 CFU/mL - treat as a UTI in pregnancy (per ACOG)
- GBS colony count <100,000 CFU/mL - does NOT require treatment as a UTI
- Any GBS detected in urine at any colony count - warrants intrapartum IV antibiotic prophylaxis (regardless of colony count) to prevent early-onset neonatal GBS sepsis
Antibiotic Safety Summary by Trimester
| Drug | 1st Trimester | 2nd Trimester | 3rd Trimester |
|---|
| Amoxicillin / Cephalexin | Safe | Safe | Safe |
| Nitrofurantoin | Avoid (birth defects) | Safe | Avoid near term (hemolysis) |
| TMP-SMX | Avoid (antifolate) | Caution | Avoid (kernicterus) |
| Trimethoprim alone | Avoid | Can use | Caution |
| Fluoroquinolones | Contraindicated | Contraindicated | Contraindicated |
| Tetracyclines | Contraindicated | Contraindicated | Contraindicated |
| Ceftriaxone (IV) | Safe | Safe | Safe |
Recent Evidence
A 2024 meta-analysis (
PMID 39258657) confirmed that UTIs in pregnancy are significantly associated with increased risk of preterm birth. A global prevalence meta-analysis (
PMID 37734277) showed wide variation in UTI prevalence across populations, reinforcing the importance of universal screening. The
IDSA 2025 complicated UTI guidelines (which classify pregnancy as a complicated UTI context) and the
AUA/CUA/SUFU 2025 rUTI guideline both support antibiotic stewardship principles and individualized regimen selection.
Key Management Principles Summary
- Screen all pregnancies for ASB at 12-16 weeks - treat if positive
- Treat ASB and cystitis with a 7-day course of a pregnancy-safe antibiotic and confirm eradication by culture
- Admit pyelonephritis - IV ceftriaxone empirically, hydrate, monitor closely
- Prophylax after pyelonephritis until delivery to prevent recurrence
- Avoid: fluoroquinolones and tetracyclines throughout; nitrofurantoin in 1st trimester and near term; TMP-SMX in 1st and 3rd trimesters
- GBS in urine requires intrapartum prophylaxis regardless of colony count